Business

Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea

Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea.

articleBionik Laboratories Corp.March 7, 20183/company/bionik-laboratories-corp/news/bionik-laboratories-corp-and-curexo-enter-exclusive-distribution-agreement-for-sale-of-robotic-rehabilitation-systems-in-us-and-south-korea
Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea

About this update from Bionik Laboratories Corp.

[{"type":"text","content":"\n\n\n\nBionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea\nAgreement further expands Bionik's footprint in Asia though Curexo's sales and distribution network in South Korea; Initial orders for each company's technology to ship in the coming weeks\nPR Newswire\nTORONTO and BOSTON, March 7, 2018\n\n\n\nTORONTO and BOSTON, March 7, 2018 /PRNewswire/ -- Bionik Laboratories Corp. (OTCQB: BNKL) (\"Bionik\" or the \"Company\"), a robotics company focused on providing rehabilitation and assistive technology solutions from hospital to home for individuals with neurological and mobility challenges, today announced it has entered into an exclusive distribution agreement for the sale of its InMotion Robotic Systems in South Korea with Curexo. As part of the agreement, Bionik also becomes the exclusive distributor of Curexo's Morning Walk lower body rehabilitation technology within the United States.\n\n\n \n \n\n \nThe agreement between the two companies will provide Curexo with the exclusive right to market and sell Bionik's innovative robotic products in South Korea, including its InMotion ARM, InMotion HAND, and InMotion WRIST, which are all interactive robotic products that assist the patients' movement as they progress through their rehabilitation. Extensive clinical data on more than 1,000 patients has demonstrated that the InMotion robots provide more effective patient outcomes than traditional manual therapy alone. Initial orders for each company's technology will ship in the coming weeks.\n\nCurexo is a manufacturer and importer of surgical and medical robots in South Korea, whose largest shareholders are Korea Yakult Corp. and Hyundai Heavy Industries. The agreement provides Bionik with the exclusive right to market and sell Curexo's Morning Walk lower body rehabilitation technology withi...

More updates from Bionik Laboratories Corp.